Navigation Links
Genetic Variation Visualization - From EMBL

"Because up to 75 percent of breast cancer patients have an abnormality in a specific cell signaling pathway, drugs that target different molecules along that pathway may be especially effective for treating the disease, says a researcher from The University of Texas M. D. Anderson Cancer Center."

A clearer picture is now emerging about the importance of the phosphatidylinositol 3 kinase (PI3K) pathway to breast cancer development, says Gordon Mills, M.D., Ph.D., a professor and chair of the Department of Molecular Therapeutics. This pathway, which is linked to critical growth factor receptors and is involved in programmed cell death, is aberrant at multiple levels in breast cancer, including mutations in PI3K itself or its many “downstream?players, such as PTEN, or AKT. “There is a lot of crosstalk between the PI3K pathway and other pathways, a lot of feed-forward and feedback loops,?says Mills. “But I and others believe there are central nodes between these intersecting circles that can be effectively targeted with drugs.?Only one PI3K pathway inhibitor is in use to date, but others are increasingly being developed and tested, says Mills, who is discussing the importance of this pathway at the annual San Antonio Breast Cancer Symposium meeting. “At least 20 different companies have recognized the importance of the pathway in breast cancer and are trying to develop drugs that target it.?In the future, breast cancer tissue samples from newly diagnosed patients can be tested for their specific PI3K pathway abnormality in order to find a drug that zeroes in on what may be the cancer’s Achilles?heel, Mills says. “Using those drugs in combination with other treatments such as chemotherapy may significantly advance breast cancer care,?he says.
'"/>

Source:


Page: 1

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Genetically modified natural killer immune cells attack, kill leukemia cells
3. Ants Genetic Engineering Leads To Species Interdependency
4. Genetically modified rice in China benefits farmers health, study finds
5. Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells
6. Genetically Modified Natural Killer Immune Cells Attack, Kill Leukemia Cells
7. Genetic defects give the immune system the green light to attack the pancreas
8. Maine Researchers Find Exceptions to Old Rules of Genetic Inheritance
9. Genetic therapy reverses nervous system damage in animal model of inherited human disease
10. Infants with Rare Genetic Disease Saved By Cord Blood Stem Cells
11. Researchers Find New Technique To Identify Fetal Genetic Material From Amniotic Fluid

Post Your Comments:
(Date:11/4/2009)...ciphered the DNA codes, or genomes, of the famed f... The Genome 10K Project, an international effort t...on 10,000 species of animals for conducting compar... achieved. , Participating in The Genome 10K pro..., 2009 issue of the Journal of Heredity , are 70 ...
(Date:11/4/2009)...0 DigitalPersona, Inc., a leader i...s, today announced that WAND Corporation, a leadin...ck-service restaurants, has integrated DigitalPers...POS solutions. WAND,s quick-service customers can ...countability and deter unauthorized manager overri...
(Date:11/4/2009)...ire-FirstCall/ -- BIO-key International, Inc. (OTC...iometric identification software is showcasing don... conference being held at the New Orleans Conventi...ovide hands-on product demonstrations of its state...4. Also, at 5 PM on Monday, October 26, Peter Lux,...
Breaking Biology News(10 mins):Singapore scientists join international study of 10,000 vertebrates' genomes 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3BIO-key(R) International Exhibiting at AABB TXPO 2New genetic research indicates Jewish priesthood has multiple lineages 10085 1New genetic research indicates Jewish priesthood has multiple lineages 10085 2Infant Head Flattening Linked to Ear Infections 58248 1Infant Head Flattening Linked to Ear Infections 58248 2Fructose Boosts Blood Pressure Studies Find 58246 1Fructose Boosts Blood Pressure Studies Find 58246 2Fructose Boosts Blood Pressure Studies Find 58246 3
...e in all shapes and sizes, from grand Redwood tree...hem, under the ground plants rely on a complex net... growth has been a mystery, but a new paper publis...pe of the existing root can determine how further ...mone concentration. The work also suggests that th...
...led warming over the last few decades has triggere...orth American and Western European lakes, say rese...stry of the Environment. , The team reports that ...te lakes similar to those previously observed in t... decades later. The Arctic has long been considere...
...ecember 22, 2008 - Shakespeare wrote "a rose by an...f the molecules that generate its,fragrance were t..., Assistant Professor of Chemistry at The City,Col...aboratory of Dr. Stuart,Firestein, Professor of Bi...te. Their findings, reported today in the journal ...
Other Biology News:Study links ecosystem changes in temperate lakes to climate warming 2Shape changes in aroma-producing molecules determine the fragrances we detect 2
(Date:11/6/2009)...PRNewswire/ -- Myriant Technologies LLC ("Myriant"...turer of renewable bio-chemicals, Uhde Corporatio... Uhde GmbH, one of the world,s leading engineering...ce for the engineering, procurement & construc...nts based on renewable feedstocks. The execution ...
(Date:11/6/2009)... Intarcia Therapeutics, Inc. deliv...S® continuous delivery of exenatide) program ...Annual Diabetes Technology Meeting in San Francisc...n/prnh/20050301/SFTU126LOGO ) ,, Continuous S...ers Plasma Glucose, HbA1c and Reduces Weight in a ...
(Date:11/5/2009)...5 DSM Pharmaceutical Products toda...nce with Galenix, Saint Jean D,Illac, France, wher...acturing partner for Galenix commercial products o...borate on business development opportunities co-ma...on the strength of Galenix in drug product develop...
(Date:11/5/2009)... BioSpecifics Technologie...any developing first-in-class collagenase-based pr...the third quarter ended September 30, 2009. ,,...is year, the FDA,s Arthritis Advisory Committee un...oval of XIAFLEX(TM) for the treatment of Dupuytren...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5
... The board of directors of Segetis,...rt as President and Chief Executive Officer of the...(Business Wire EON) September 3, 2008 -- Segetis ...al "binary code" for developing a wide r... ultimately derived from non-food agricultural and...
...CO, Sept. 3 Osprey Pharmaceuticals U.S.A., a,priv...tein therapeutics,that selectively target chemokin...itiating and maintaining inflammatory diseases, an...ion in its first round of venture capital,funding....articipation from,Novo Nordisk Biotech Fund (Novo ...
...., Sept. 3 Plexus Corp. (Nasdaq:,PLXS) announced ...ngzhou,China and has entered into an agreement to ...jiang Hi-Tech Park located in Hangzhou. The new,fa...stomers with regional,decision centers in the grea... to deliver a lowest total cost value proposition....
Other Biology Technology: Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc 2Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing 2Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing 3Plexus Announces Expansion in Hangzhou, China 2Plexus Announces Expansion in Hangzhou, China 3
Essential Data: Centrifugation from Promega
rNeural Stem Cell (rNSC)Kit from AlphaGenix, Inc.
Rabbit anti-JLP AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Proteins LabFax from Promega
Biology Products: